MAPK9 and lung adenocarcinoma: Li et al. discovered that MEG3 and MIAT may foster the progression of lung adenocarcinoma through interacting with miR-106, thus regulating the involvement of MAPK9 in the MAPK signal transduction pathways (Li et al., 2016).